Click Here For Spanish Version of This Page / Versión en español de esta página
Click Here For Hebrew Version of This Page
Click Here For Russian Version of This Page
Click Here For Ukrainian Version of This Page
Click Here For Korean Version of This Page
Research Trials
December, 2024 – Cognition Therapeutics Announces Positive Results in Phase 2 Study of CT1812 in Dementia with Lewy Bodies. They released their data from the SHIMMER study in an investor call. You can listen to the recorded call here:
https://ir.cogrx.com/events/investor-webinar-analysis-of-topline-phase-2-dlb-results/